Landfar Bio-medicine Co., Ltd (SHE:000504)
China · Delayed Price · Currency is CNY 8.11
+0.32 (4.11%)
Aug 4, 2026, 3:04 PM CST
Landfar Bio-medicine Market Cap
Landfar Bio-medicine has a market cap or net worth of 2.68 billion as of August 4, 2026. Its market cap has decreased by -26.07% in one year.
Market Cap
2.68B
Enterprise Value
2.82B
Revenue
512.79M
Ranking
n/a
PE Ratio
61.60
Stock Price
8.11
ChartMarket Cap Chart
Since October 24, 2002, Landfar Bio-medicine's market cap has decreased from 2.85B to 2.68B, a decrease of -6.21%. That is a compound annual growth rate of -0.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 2.68B | -9.39% |
| Dec 31, 2025 | 2.95B | 7.19% |
| Dec 31, 2024 | 2.76B | -23.75% |
| Dec 29, 2023 | 3.61B | -0.34% |
| Dec 30, 2022 | 3.63B | -37.42% |
| Dec 31, 2021 | 5.80B | 51.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zhejiang Shouxiangu Pharmaceutical | 2.96B |
| Guanhao Biotech | 2.94B |
| Qingdao Vland Biotech INC. | 2.92B |
| Guangdong VTR Bio-Tech | 2.80B |
| Hubei Goto Biopharm Group | 2.80B |
| Beijing Kawin Technology Share-Holding | 2.72B |
| Yantai Zhenghai Biotechnology | 2.60B |
| Shenzhen Bioeasy Biotechnology | 2.58B |